Skip to main content
. 2018 Apr 18;16:7. doi: 10.1186/s12959-017-0156-y

Table 2.

Percentage of adherent patients per NOAC

Pct of patients
PDC* > =80 Nr of patients
Apixaban 92% 7094
Dabigatran 88% 11,782
Rivaroxaban 88% 13,975
Total 89% 32,851